Non-invasive imaging has been impacted significantly with programs describing as much as a 90% reduction in their volumes in March and April of this year compared to last year. Successful reemergence will require considerations for patient flow, safety requirements and clinical prioritization for ramp up. This chapter starts with an overview of several recent changes allowing for broader team support of your testing services. Thanks to CMS, APPs are allowed to supervise testing and there is some flexibility around physician supervision requirements. These are changes that we hope will remain after the pandemic has subsided.

DIAGNOSTIC TESTING SUPERVISION

On April 30, 2020, CMS released another waiver that includes the ability for APPs to supervise stress testing.